Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$54,796,481
-$40,222,854 QoQ
Shares Held
42,809,751
-32.9% QoQ
Ownership
6.66%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#2
of 259 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. GERN ranks #37 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,796,481 | 42,809,751 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $85,123,491 | 66,502,728 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,019,335 | 63,771,366 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $84,178,203 | 63,771,366 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $82,719,731 | 60,379,366 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $85,134,906 | 60,379,366 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $96,003,191 | 60,379,366 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $106,233,757 | 30,009,536 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $146,577,327 | 32,285,755 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $195,898,282 | 46,202,425 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $152,468,002 | 46,202,425 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $97,487,116 | 46,202,425 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $97,949,141 | 46,202,425 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $101,258,827 | 31,544,806 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $68,452,229 | 31,544,806 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,292,320 | 12,930,711 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $70,495,539 | 30,126,299 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $46,695,763 | 30,126,299 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $40,971,766 | 30,126,299 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $36,754,084 | 30,126,299 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $41,273,029 | 30,126,299 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,478,081 | 30,126,299 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,599,552 | 30,126,299 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $47,900,815 | 30,126,299 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $52,419,760 | 30,126,299 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $65,675,331 | 30,126,299 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||